Biotech | April 04, 2022
Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
Supply increase to help meet growing global demand
Supply increase to help meet growing global demand
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
The plant is scheduled to come on stream in September 2024
BVX-0922 to target colorectal cancer under investigator-sponsored IND
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
Subscribe To Our Newsletter & Stay Updated
